Mechanisms Involved in Childhood Obesity-Related Bone Fragility

Childhood obesity is one of the major health problems in western countries. The excessive accumulation of adipose tissue causes inflammation, oxidative stress, apoptosis, and mitochondrial dysfunctions. Thus, obesity leads to the development of severe co-morbidities including type 2 diabetes mellitus, liver steatosis, cardiovascular, and neurodegenerative diseases which can develop early in life. Furthermore, obese children have low bone mineral density and a greater risk of osteoporosis and fractures. The knowledge about the interplay bone tissue and between adipose is still growing, although recent findings suggest that adipose tissue activity on bone can be fat-depot specific. Obesity is associated to a low-grade inflammation that alters the expression of adiponectin, leptin, IL-6, Monocyte Chemotactic Protein 1 (MCP1), TRAIL, LIGHT/TNFSF14, OPG, and TNFα. These molecules can affect bone metabolism, thus resulting in osteoporosis. The purpose of this review was to deepen the cellular mechanisms by which obesity may facilitate osteoporosis and bone fractures

Caractérisation de l'implication de l'hélicase DHX9 (RHA) dans le cycle de multiplication du virus Chikungunya

Viruses are obligate intracellular parasites recruiting cellular cofactors to divert different biological processes enabling them to replicate their genome and to form other viral particles. If cellular cofactors of Semliki Forest virus replication have recently been identified, very few studies have revealed the replication partners of the very close Alphavirus Chikungunya (CHIKV). During this study, We have discovered recruitments of several DExD/H Box Helicases at the CHIKV replication sites. Among them, DHX9 or RNA Helicase A (RHA) through its RNA binding properties and in modulating RNA secondary structures or Ribonucleoproteins complexes, is involved in various functions from transcription, translation, replication of genomes and up to production of infectious particles of many viruses. In the case of Chikungunya virus, we have characterized a proviral function in the translation of non-structural proteins and an antiviral function in the genome replication. These opposite functions are manipulated by CHIKV to ensure production nonstructural proteins, components of the CHIKV replication complex while maintaining its replication. These works reveal a new translation regulation mechanism of CHIKV genomic RNA and bring some knowledge on the passage from the translation stage to the replication step of CHIKV genome.Les virus sont des parasites intracellulaires obligatoires recrutant des cofacteurs cellulaires afin de détourner les différents processus biologiques leur permettant notamment de répliquer leur génome et de former d'autres particules virales. Si des cofacteurs cellulaires de la réplication du virus Semliki Forest ont été récemment identifiés, très peu d'études ont permis de révéler des partenaires de la réplication du proche Alphavirus Chikungunya (CHIKV). Nous avons découvert, au cours de cette étude, un recrutement d'Hélicases à domaine DExD/H au niveau de sites de réplication du CHIKV. Parmi elles, DHX9 ou RNA Helicase A (RHA), grâce à ses propriétés de liaison et de modulation de structures des ARNs ou de complexes de Ribonucléoprotéines, est impliquée dans diverses fonctions depuis la transcription, la traduction, la réplication de génomes et jusqu'à la production de particules infectieuses de nombreux virus. Dans le cas du virus Chikungunya, nous avons caractérisé une fonction provirale dans la traduction de protéines non-structurales et une fonction antivirale dans la réplication du génome. Cette double fonction opposée est manipulée par le CHIKV afin d'assurer une production de protéines non-structurales composant le complexe de réplication tout en maintenant sa réplication. Ces travaux révèlent un nouveau mécanisme de régulation de la traduction d'ARN génomique de CHIKV et apportent des éléments de compréhension dans la dynamique de passage du phénomène de traduction à l'étape de réplication du génome CHIKV

Characterization of the involvement of the helicase DHX9 (RHA) in the multiplication cycle of the Chikungunya virus

Les virus sont des parasites intracellulaires obligatoires recrutant des cofacteurs cellulaires afin de détourner les différents processus biologiques leur permettant notamment de répliquer leur génome et de former d'autres particules virales. Si des cofacteurs cellulaires de la réplication du virus Semliki Forest ont été récemment identifiés, très peu d'études ont permis de révéler des partenaires de la réplication du proche Alphavirus Chikungunya (CHIKV). Nous avons découvert, au cours de cette étude, un recrutement d'Hélicases à domaine DExD/H au niveau de sites de réplication du CHIKV. Parmi elles, DHX9 ou RNA Helicase A (RHA), grâce à ses propriétés de liaison et de modulation de structures des ARNs ou de complexes de Ribonucléoprotéines, est impliquée dans diverses fonctions depuis la transcription, la traduction, la réplication de génomes et jusqu'à la production de particules infectieuses de nombreux virus. Dans le cas du virus Chikungunya, nous avons caractérisé une fonction provirale dans la traduction de protéines non-structurales et une fonction antivirale dans la réplication du génome. Cette double fonction opposée est manipulée par le CHIKV afin d'assurer une production de protéines non-structurales composant le complexe de réplication tout en maintenant sa réplication. Ces travaux révèlent un nouveau mécanisme de régulation de la traduction d'ARN génomique de CHIKV et apportent des éléments de compréhension dans la dynamique de passage du phénomène de traduction à l'étape de réplication du génome CHIKV.Viruses are obligate intracellular parasites recruiting cellular cofactors to divert different biological processes enabling them to replicate their genome and to form other viral particles. If cellular cofactors of Semliki Forest virus replication have recently been identified, very few studies have revealed the replication partners of the very close Alphavirus Chikungunya (CHIKV). During this study, We have discovered recruitments of several DExD/H Box Helicases at the CHIKV replication sites. Among them, DHX9 or RNA Helicase A (RHA) through its RNA binding properties and in modulating RNA secondary structures or Ribonucleoproteins complexes, is involved in various functions from transcription, translation, replication of genomes and up to production of infectious particles of many viruses. In the case of Chikungunya virus, we have characterized a proviral function in the translation of non-structural proteins and an antiviral function in the genome replication. These opposite functions are manipulated by CHIKV to ensure production nonstructural proteins, components of the CHIKV replication complex while maintaining its replication. These works reveal a new translation regulation mechanism of CHIKV genomic RNA and bring some knowledge on the passage from the translation stage to the replication step of CHIKV genome

Vpx n’a pas dit son dernier mot « HUSH » !

International audienceNo abstract availabl

HUSH-mediated HIV silencing is independent of TASOR phosphorylation on threonine 819

International audienceBackground: TASOR, a component of the HUSH repressor epigenetic complex, and SAMHD1, a cellular triphosphohydrolase (dNTPase), are both anti-HIV proteins antagonized by HIV-2/SIVsmm Viral protein X. As a result, the same viral protein is able to relieve two different blocks along the viral life cell cycle, one at the level of reverse transcription, by degrading SAMHD1, the other one at the level of proviral expression, by degrading TASOR. Phosphorylation of SAMHD1 at T592 has been shown to downregulate its antiviral activity. The discovery that T819 in TASOR was lying within a SAMHD1 T592-like motif led us to ask whether TASOR is phosphorylated on this residue and whether this post-translational modification could regulate its repressive activity.Results: Using a specific anti-phospho-antibody, we found that TASOR is phosphorylated at T819, especially in cells arrested in early mitosis by nocodazole. We provide evidence that the phosphorylation is conducted by a Cyclin/CDK1 complex, like that of SAMHD1 at T592. While we could not detect TASOR in quiescent CD4 + T cells, TASOR and its phosphorylated form are present in activated primary CD4 + T lymphocytes. In addition, TASOR phosphorylation appears to be independent from TASOR repressive activity. Indeed, on the one hand, nocodazole barely reactivates HIV-1 in the J-Lat A1 HIV-1 latency model despite TASOR T819 phosphorylation. On the other hand, etoposide, a second cell cycle arresting drug, reactivates latent HIV-1, without concomitant TASOR phosphorylation. Furthermore, overexpression of wt TASOR or T819A or T819E similarly represses gene expression driven by an HIV-1-derived LTR promoter. Finally, while TASOR is degraded by HIV-2 Vpx, TASOR phosphorylation is prevented by HIV-1 Vpr, likely as a consequence of HIV-1 Vpr-mediated-G2 arrest.Conclusions: Altogether, we show that TASOR phosphorylation occurs in vivo on T819. This event does not appear to correlate with TASOR-mediated HIV-1 silencing. We speculate that TASOR phosphorylation is related to a role of TASOR during cell cycle progression

MORC2 restriction factor silences HIV proviral expression

Abstract The HUSH complex (composed of TASOR, MPP8 and periphilin) represses HIV-1 expression from its promoter by inducing both propagation of repressive epigenetic marks and degradation of the nascent transcript. Vpx from HIV-2, and Vpr proteins from some simian lentiviruses (SIVs), antagonize HUSH, thereby increasing proviral expression. The chromatin-remodelling MORC2 protein plays a critical role in the epigenetic silencing of host genes by HUSH. Here, we deciphered the role of MORC2 in retroviral silencing. We show that MORC2, in contrast to HUSH components, presents strong signatures of positive selection during primate evolution. Like HUSH, MORC2 represses proviral expression in two models of HIV-1 latency. However, while HUSH is degraded upon HIV-2 infection in a Vpx-dependent manner, MORC2 levels are increased, raising the question of a feedback control mechanism without HUSH. Upon infection with an HIV-1-derived virus, MORC2 and TASOR antiviral effects are interdependent. However, once the lentiviral DNA is integrated into the host genome, MORC2 may maintain the repression independently of HUSH. At the post-transcriptional level, both MORC2 and HUSH act in association with CNOT1 of the CCR4-NOT deadenylase complex and the TRAMP-like PAXT complex. Finally, MORC2, but not HUSH components, is expressed in primary quiescent CD4+ T cells. Altogether, our data highlight MORC2 as an HIV restriction factor and a chromatin remodelling protein operating both at the transcriptional and post-transcriptional levels. We speculate that MORC2 could serve as an immune gatekeeper following HUSH inactivation by Vpx and contribute to the maintenance of retroviral silencing in reservoir CD4+ T cells. Significance statement One hurdle to HIV eradication is viral latency, which refers to the persistence of the virus in reservoir cells despite antiretroviral treatment. The HUSH complex represses HIV expression, once the viral genome is integrated into the host genome. HUSH activity on host genes depends on MORC2, a protein incriminated in the Charcot-Marie-Tooth neuronal disease. Here, we first show that MORC2 presents signs of evolutionary arms-races in primates. Furthermore, MORC2 contributes to HIV silencing in cooperation with HUSH, but also, likely without HUSH. Despite identified as a chromatin remodeler, MORC2 also works at a post-transcriptional level. Altogether, MORC2 appears as a host defense factor, which plays a role in HIV latency

The Host DHX9 DExH-Box Helicase Is Recruited to Chikungunya Virus Replication Complexes for Optimal Genomic RNA Translation

International audienceBeyond their role in cellular RNA metabolism, DExD/H-box RNA heli-cases are hijacked by various RNA viruses in order to assist replication of the viral genome. Here, we identify the DExH-box RNA helicase 9 (DHX9) as a binding partner of chikungunya virus (CHIKV) nsP3 mainly interacting with the C-terminal hypervari-able domain. We show that during early CHIKV infection, DHX9 is recruited to the plasma membrane, where it associates with replication complexes. At a later stage of infection, DHX9 is, however, degraded through a proteasome-dependent mechanism. Using silencing experiments, we demonstrate that while DHX9 negatively controls viral RNA synthesis, it is also required for optimal mature nonstructural protein translation. Altogether, this study identifies DHX9 as a novel cofactor for CHIKV repli-cation in human cells that differently regulates the various steps of CHIKV life cycle and may therefore mediate a switch in RNA usage from translation to replication during the earliest steps of CHIKV replication. IMPORTANCE The reemergence of chikungunya virus (CHIKV), an alphavirus that is transmitted to humans by Aedes mosquitoes, is a serious global health threat. In the absence of effective antiviral drugs, CHIKV infection has a significant impact on human health, with chronic arthritis being one of the most serious complications. The molecular understanding of host-virus interactions is a prerequisite to the development of targeted therapeutics capable to interrupt viral replication and transmission. Here, we identify the host cell DHX9 DExH-Box helicase as an essential cofactor for early CHIKV genome translation. We demonstrate that CHIKV nsP3 protein acts as a key factor for DHX9 recruitment to replication complexes. Finally, we establish that DHX9 behaves as a switch that regulates the progression of the viral cycle from translation to genome replication. This study might therefore have a significant impact on the development of antiviral strategies. KEYWORDS chikungunya virus, DHX9, RNA helicase, nsP3, viral replication T he chikungunya virus (CHIKV), a mosquito-borne alphavirus transmitted by Aedes mosquitoes, represents an ongoing challenge to medicine and public health. The clinical manifestation of CHIKV infection is an acute syndrome (high fever, rash, myalgia, and intense arthralgia) that coincides with high viremia. In the absence of targeted therapeutics the infection evolves into a chronic incapacitating arthralgia in the distal joints in more than half of the cases, with patients requiring long-term administration of anti-inflammatory and immunosuppressive treatment (for a review, see reference 1). Because CHIKV recently caused major outbreaks worldwide with a disastrous socioeconomic impact and because antiviral molecules are still lacking, there is an urgent need to identify the mechanisms of infection that might be targeted therapeutically. Citation Matkovic R, Bernard E, Fontanel S, Eldin P, Chazal N, Hassan Hersi D, Merits A, Péloponèse J-M, Briant L. 2019. The host DHX9 DExH-box helicase is recruited to chikungunya virus replication complexes for optimal genomic RNA translation. J Virol 93:e01764-18

HIV-2/SIV viral protein X counteracts HUSH repressor complex

International audienceTo evade host immune defences, human immunodeficiency viruses 1 and 2 (HIV-1 and HIV-2) have evolved auxiliary proteins that target cell restriction factors. Viral protein X (Vpx) from the HIV-2/SIVsmm lineage enhances viral infection by antagonizing SAMHD1 (refs 1,2), but this antagonism is not sufficient to explain all Vpx phenotypes. Here, through a proteomic screen, we identified another Vpx target-HUSH (TASOR, MPP8 and periphilin)-a complex involved in position-effect variegation3. HUSH downregulation by Vpx is observed in primary cells and HIV-2-infected cells. Vpx binds HUSH and induces its proteasomal degradation through the recruitment of the DCAF1 ubiquitin ligase adaptor, independently from SAMHD1 antagonism. As a consequence, Vpx is able to reactivate HIV latent proviruses, unlike Vpx mutants, which are unable to induce HUSH degradation. Although antagonism of human HUSH is not conserved among all lentiviral lineages including HIV-1, it is a feature of viral protein R (Vpr) from simian immunodeficiency viruses (SIVs) of African green monkeys and from the divergent SIV of l'Hoest's monkey, arguing in favour of an ancient lentiviral species-specific vpx/vpr gene function. Altogether, our results suggest the HUSH complex as a restriction factor, active in primary CD4+ T cells and counteracted by Vpx, therefore providing a molecular link between intrinsic immunity and epigenetic control

Montpellier Infectious Diseases -Pôle Rabelais (MID) 3rd annual meeting (2014)

International audienceFor the third time, teams belonging to the "Montpellier Infectious Diseases" network in the Rabelais BioHealth Cluster held their annual meeting on the 27th and 28th of November in Montpellier, France. While the 2012 meeting was focused on the cooperation between the local force tasks in biomedical and medical chemistry and presented the interdisciplinary research programs designed to fight against virus, bacteria and parasites, the 2014 edition of the meeting was focused on the translational research in infectious diseases and highlighted the bench-to-clinic strategies designed by academic and private research groups in the Montpellier area